SGS Biopharma

SGS Biopharma is a multi-disciplined CRO focusing on early development (phase I clinical trials (78 bed unit)), analytical services (bioanalysis) and data management/statistics. Clinical supplies and later stage complete our host of services.

Activity:

- Clinical Trials
- Contract Research
- Regulatory Affairs & Legal Services

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Cosmoceuticals
- Curative
- Devices
- Diagnostics
- Enzymes
- Generics
- FP (finished products)
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Phyto
- Nutritionals / Vitamins
- Proteins

Therapeutic targets:

- Allergy
- Arthritis / Rheumato
- Asthma
- Cardiovascular
- Central nervous system
- Dermatology
- Epidemiology
- Gastrointestinal
- Hematology
- Infectious Diseases
- Ophthalmology
- Pain
- Radiology
- Respiratory Medicine

Markets Covered

a. HeadQuarter: Belgium

b. Continent(s) active: Europe , North America

c. Countries active: USA, Belgium, Italy

Corporate data:

Number of Employees: 175

Turnover:

Amount:	Year:	Currency:
20370000	2002	Euro

Year founded: 1970

Partners / Alliances: Parent company: Société Générale de Surveillance: SGS (Exchange: SWX , Zürich, part of Swiss Market Index)